On September 11, 2023, Aimed Alliance sent a letter to Centers for Medicare and Medicaid Services (CMS) commenting on CMS’s…
Browsing: Drug Pricing
On January 17, 2023, the Institute for Clinical and Economic Review (ICER) published its second annual “Barriers to Fair Access”…
On November 26, 2021, Aimed Alliance sent a letter to U.S. Senators Carper, Coons, Cortez, Masto, Menendez, Murray, Sinema, Schumer and Wyden…
On October 12, 2021, Aimed Alliance submitted a comment to the Centers for Medicare & Medicaid Services (CMS) on its proposed rule…
A new op-ed by Dr. Chris Stansbury details a potential new approach for Congress in controlling prescription drug prices: regulating…
Aimed Alliance has created a new fact sheet dedicated to H.R. 3, otherwise known as the Elijah E. Cummings Lower…
On May 4, 2021, Aimed Alliance submitted a letter in support of Connecticut HB 6242 to members of the Connecticut…
On January 28, 2021, Aimed Alliance submitted a letter requesting that the Centers for Medicare & Medicaid Services (CMS) reverse…
On January 26, 2021, Aimed Alliance submitted a comment to the Centers for Medicare & Medicaid Services (CMS) in response…
On December 21, 2020, the Centers for Medicare and Medicaid Services (CMS) finalized a rule to alter the method by…